Immune‐mediated hemolytic anemia (IMHA) causes severe anemia in dogs and is
associated with considerable morbidity and mortality. Treatment with various …

Interindividual variation in drug response occurs in canine patients just as it does in human
patients. Although canine pharmacogenetics still lags behind human pharmacogenetics …

Cutaneous vasculitis is an inflammatory process targeting blood vessels. Underlying factors
include drugs, infectious diseases, adverse reactions to food, malignancies, and immune …

Background The use of azathioprine (AZA) in dogs is limited by the development of
hepatotoxicosis and cytopenias. Hypothesis and Objectives To characterize the observed …

Immunomodulators, immunostimulants and immunotherapies are important tools used by
practitioners and researchers to direct and control the immune system and its response. This …

Pharmacokinetics can be thought of as everything that the body does to the drug after
administration and includes absorption, distribution, metabolism, and excretion …

Objective—To determine pharmacokinetics of azathioprine (AZA) and clinical, hematologic,
and serologic effects of IV and oral administration of AZA in horses. Animals—6 horses …

Immunosuppressive drugs are the mainstay of treatment for many feline and canine
autoimmune skin diseases, either as monotherapy or in combination with other drugs …

We interpret this to mean that Goodwin and coauthors find it difficult to accept that there may
be a small subset of cats, which for whatever reason, are uniquely susceptible to the …

Background The use of azathioprine (AZA) in dogs is limited by the potential for
hepatotoxicity and myelosuppression. Hypothesis/Objectives To determine the prevalence …